Cargando…
P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071991/ http://dx.doi.org/10.1186/2051-1426-2-S2-P43 |
| _version_ | 1782322884795957248 |
|---|---|
| author | Richard, K Schober, S Rami, M Mall, S Merl, J Slotta-Huspenina, J Stevanovic, S Busch, DH Peschel, C Krackhardt, AM |
| author_facet | Richard, K Schober, S Rami, M Mall, S Merl, J Slotta-Huspenina, J Stevanovic, S Busch, DH Peschel, C Krackhardt, AM |
| author_sort | Richard, K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4071991 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40719912014-06-27 P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias Richard, K Schober, S Rami, M Mall, S Merl, J Slotta-Huspenina, J Stevanovic, S Busch, DH Peschel, C Krackhardt, AM J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4071991/ http://dx.doi.org/10.1186/2051-1426-2-S2-P43 Text en Copyright © 2014 Richard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Richard, K Schober, S Rami, M Mall, S Merl, J Slotta-Huspenina, J Stevanovic, S Busch, DH Peschel, C Krackhardt, AM P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias |
| title | P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias |
| title_full | P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias |
| title_fullStr | P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias |
| title_full_unstemmed | P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias |
| title_short | P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias |
| title_sort | p69. targeting naturally presented, leukemia-derived hla ligands with tcr-transgenic t cells for the treatment of therapy refractory leukemias |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071991/ http://dx.doi.org/10.1186/2051-1426-2-S2-P43 |
| work_keys_str_mv | AT richardk p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT schobers p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT ramim p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT malls p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT merlj p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT slottahuspeninaj p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT stevanovics p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT buschdh p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT peschelc p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias AT krackhardtam p69targetingnaturallypresentedleukemiaderivedhlaligandswithtcrtransgenictcellsforthetreatmentoftherapyrefractoryleukemias |